Skip to main content
Barbara J. Kuter on Muck Rack

Barbara J. Kuter

As seen in: MDPI, JAMA (The Journal of the American Medical Association), The New England Journal of Medicine, Contemporary Pediatrics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara J.

Contact Barbara J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients

|
By Christopher Dukes, Jeffrey E. Lancet, Barbara J. Kuter, Marine Potez
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Evaluating the safety of a rotavirus vaccine: the REST of the story

|
By Barbara J. Kuter, Michael Dallas, Joseph F Heyse, aMerck Research Laboratories
| ncbi.nlm.nih.gov
Journal List SAGE Choice PMC2602609 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer.
Open in Who Shared Issue with article?

Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination

|
By Bethany Girard, Joanne E. Tomassini, Barbara J. Kuter, David C. Montefiori
| The New England Journal of Medicine Verified
To the Editor: Bivalent messenger RNA (mRNA) vaccines containing the ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and B.1.1.529 (omicron) variant spike sequences were recently made available to address the waves of infection and coronavirus disease 2019 (Covid-19) caused by omicron variants.
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)